Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: Insights from the mouse-implications for the human

Journal of Steroid Biochemistry and Molecular Biology

Volumn 102, Issue 1-5 SPEC. ISS., 2006, Pages 22-31

  Mukherjee, Atish ^a   Amato, Paula ^a   Allred, D Craig ^b   Fernandez Valdivia, Rodrigo ^a   Nguyen, Jonathan ^a   O'Malley, Bert W ^a   DeMayo, Francesco J ^a   Lydon, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Human; Mammary gland; Mouse; Progesterone receptor; SRC2; Uterus

Indexed keywords

ANIMALS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MORPHOGENESIS; NUCLEAR RECEPTOR COACTIVATOR 2; PROGESTERONE; PROTEIN TRANSPORT; RECEPTORS, PROGESTERONE; UTERUS;

EID: 33750976388     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.09.007     Document Type: Article

References (45)

1. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery Jr. C.A., Shyamala G., Conneely O.M., and O'Malley B.W. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Develop. 9 (1995) 2266-2278
2. Lydon J.P., Ge G., Kittrell F.S., Medina D., and O'Malley B.W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59 (1999) 4276-4284
3. Chatterton Jr. R.T., Lydon J.P., Mehta R.G., Mateo E.T., Pletz A., and Jordan V.C. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett. 188 (2002) 47-52
4. Medina D., Kittrell F.S., Shepard A., Contreras A., Rosen J.M., and Lydon J. Hormone dependence in premalignant mammary progression. Cancer Res. 63 (2003) 1067-1072
5. Jull J.W. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain. J. Path. Bact. 68 (1954) 547-559
6. Robinson S.P., and Jordan V.C. Reversal of antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model. Cancer Res. 47 (1987) 5386-5390
7. Russo I.H., and Russo J. Progestagens and mammary gland development: differentiation versus carcinogenesis. Acta Endocrinol. 125 (1991) 7-12
8. Aldaz C.M., Liao Q.Y., La Bate M., and Johnston D.A. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis 17 (1996) 2069-2072
9. Colditz G.A., Egan K.M., and Stampfer M.J. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am. J. Obstet. Gynecol. 168 (1993) 1473-1480
10. Schairer C., Lubin J., Troisi R., Sturgeon S., Brinton L., and Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk [see comments]. JAMA 283 (2000) 485-491
11. Ross R.K., Paganini-Hill A., Wan P.C., and Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92 (2000) 328-332
12. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 (2002) 321-333
13. Beral V. Breast cancer and hormone-replacement therapy in the million women study. Lancet 362 (2003) 419-427
14. Das S.K., Chakraborty I., Paria B.C., Wang X.N., Plowman G., and Dey S.K. Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol. Endocrinol. 9 (1995) 691-705
15. Lim H., Ma L., Ma W.G., Maas R.L., and Dey S.K. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol. Endocrinol. 13 (1999) 1005-1017
16. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., and Weinberg R.A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Develop. 14 (2000) 650-654
17. Cheon Y.P., Li Q., Xu X., DeMayo F.J., Bagchi I.C., and Bagchi M.K. A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation. Mol. Endocrinol. 16 (2002) 2853-2871
18. Takamoto N., Zhao B., Tsai S.Y., and DeMayo F.J. Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus. Mol. Endocrinol. 16 (2002) 2338-2348
19. Ismail P.M., DeMayo F.J., Amato P., and Lydon J.P. Progesterone induction of calcitonin expression in the murine mammary gland. J. Endocrinol. 180 (2004) 287-295
20. Jeong J.W., Lee K.Y., Kwak I., White L.D., Hilsenbeck S.G., Lydon J.P., and DeMayo F.J. Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology 146 (2005) 3490-3505
21. McKenna N.J., and O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 (2002) 465-474
22. Lonard D.M., and O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 30 (2005) 126-132
23. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., and O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279 (1998) 1922-1925
24. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., and O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6379-6384
25. Kuang S.Q., Liao L., Wang S., Medina D., O'Malley B.W., and Xu J. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res. 65 (2005) 7993-8002
26. Han S.J., DeMayo F.J., Xu J., Tsai S.Y., Tsai M.J., and O'Malley B.W. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol. Endocrinol. 20 (2006) 45-55
27. Gehin M., Mark M., Dennefeld C., Dierich A., Gronemeyer H., and Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol. 22 (2002) 5923-5937
28. Soyal S.M., Mukherjee A., Lee K.Y., Li J., Li H., DeMayo F.J., and Lydon J.P. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41 (2005) 58-66
29. Jeong J.W., Kwak I., Lee K.Y., White L.D., Wang X.P., Brunicardi F.C., O'Malley W., and DeMayo B.F.J. The genomic analysis of the impact of steroid receptor coactivators (SRCs) ablation on hepatic metabolism. Mol. Endocrinol. 20 (2006) 1138-1152
30. Mukherjee A., Soyal S.M., Fernandez-Valdivia R., Gehin M., Chambon P., DeMayo F.J., Lydon J.P., and O'Malley B.W. Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol. Cell. Biol. 26 (2006) 6571-6583
31. Picard F., Gehin M., Annicotte J., Rocchi S., Champy M.F., O'Malley B.W., Chambon P., and Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111 (2002) 931-941
32. Cvoro A., Tzagarakis-Foster C., Tatomer D., Paruthiyil S., Fox M.S., and Leitman D.C. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol. Cell 21 (2006) 555-564
33. Wei X., Xu H., and Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol. Cell 21 (2006) 295-305
34. Hofman K., Swinnen J.V., Verhoeven G., and Heyns W. Coactivation of an endogenous progesterone receptor by TIF2 in COS-7 cells. Biochem. Biophys. Res. Commun. 295 (2002) 469-474
35. Culig Z., Klocker H., Bartsch G., and Hobisch A. Androgen receptors in prostate cancer. Endocr. Relat. Cancer 9 (2002) 155-170
36. Berrevoets C.A., Umar A., Trapman J., and Brinkmann A.O. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Biochem. J. 379 (2004) 731-738
37. Ye X., Han S.J., Tsai S.Y., DeMayo F.J., Xu J., Tsai M.J., and O'Malley B.W. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9487-9492
38. Clarke R.B., Howell A., Potten C.S., and Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57 (1997) 4987-4991
39. Fernandez-Valdivia R., Mukherjee A., Mulac-Jericevic B., Conneely O.M., DeMayo F.J., Amato P., and Lydon J.P. Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse. Semin. Reprod. Med. 23 (2005) 22-37
40. Norwitz E.R., Schust D.J., and Fisher S.J. Implantation and the survival of early pregnancy. N. Engl. J. Med. 345 (2001) 1400-1408
41. Gregory C.W., Wilson E.M., Apparao K.B., Lininger R.A., Meyer W.R., Kowalik A., Fritz M.A., and Lessey B.A. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J. Clin. Endocrinol. Metab. 87 (2002) 2960-2966
42. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., Sellers W.R., and Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6 (2004) 263-274
43. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., and Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 (1997) 965-968
44. Lonard D.M., Tsai S.Y., and O'Malley B.W. Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Mol. Cell. Biol. 24 (2004) 14-24
45. Lee S., Mohsin S.K., Mao S., Hilsenbeck S.G., Medina D., and Allred D.C. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res. 8 (2005) 1-9